By selecting the Yes option, leaving Amgen.com.sg option you understand that you are leaving the corporate page of Amgen Singapore and that you will be redirected to another Internet site belonging to third parties, for whose content or opinions Amgen Singapore is not responsible and makes no representations regarding such content or its accuracy. By selecting this option and accessing linked third party sites, you understand that you do so at your own risk.
The website to which you will be redirected may be designed exclusively for residents of a particular country or countries, as advertised on that website. As a consequence, the website to which you will be directed may contain information on pharmaceutical products or indications that are not approved in Singapore. If You reside in a country other than the one to which such website is directed, please contact your local Amgen affiliate for the correct information on products in your country of residence.
Amgen is one of the world’s leading biotechnology companies, present in more than 100 countries and with a global team of 23,000 employees.
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
Our belief – and the core of our strategy – is that innovative, highly differentiated medicines that provide large clinical benefits in addressing serious diseases are medicines that will not only help patients, but also will help reduce the social and economic burden of disease in society today.
A biotechnology innovator since 1980, Amgen has grown to be one of the world’s leading independent biotechnology companies, reaching millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
The rhythm of life unfolds at an ever-changing pace. Some moments pass in a blur. Others tick by in slow motion.
But no matter what the pace of life, nothing is more valuable than the time we have to experience it— and the chance we have to live each moment to its fullest.
That’s why Amgen operates at a different rhythm, moving quickly toward the future by combatting the world’s toughest diseases.
With roots in the biotech revolution, today Amgen is one of the world’s leading independent biotech companies.
With each decade, we stay on the cutting edge of medical discovery, inventing powerful therapies— and reliably delivering them to patients.
We fight the toughest diseases, such as cancer, heart disease, asthma, and osteoporosis to help millions of people globally.
We live in a new era of human health. And Amgen continues to accelerate the pace of change-- operating sustainably and drawing upon our deep knowledge of science to push beyond what’s known today.
We tap into a vast library of human and genetic data to unearth new insights into treating disease. We are creating new therapies that are more precise and personalized than ever before, advancing medicines that can work in new ways, such as targeting multiple pathways in the body at the same time.
Machine learning and artificial intelligence help us make medicines more quickly and effectively by helping to predict if they’ll be safe and effective.
We’re also removing barriers that limit equitable access to healthcare to make our medicines available to more patients around the world.
At Amgen, our mission is to serve patients because we want these rhythms of life to continue. We want you, and your loved ones, to make every moment count—and to count on having more moments
Singapore is home to Amgen’s first manufacturing site in Asia and the pioneering site of its groundbreaking Next Generation biologics manufacturing facility. Further strengthening our advanced manufacturing capabilities, our expanding footprint now includes a chemical synthesis facility and a growing commercial affiliate presence. This expansion aims to serve more patients and meet the growing healthcare demands of the region, while delivering treatments to millions worldwide.
Singapore also serves as the strategic hub for Amgen’s Japan Asia Pacific (JAPAC) operations. Amgen currently serves over 3.7 million patients across JAPAC and we continue to expand our impact on patients through innovative and high-quality therapies.
We collaborate closely with healthcare providers, industry partners, academia, and the community to drive scientific innovation, advance medical breakthroughs, and enhance patient outcomes. Through strategic partnerships with key stakeholders, our commitment extends to accelerating the growth of innovative biotech startups and fostering collaboration within Singapore’s biotech sector. Supported by initiatives from the Amgen Foundation, we promote excellence in science education to inspire the next generation of biomedical innovators.
At the heart of Amgen Singapore is our diverse workforce, whose collective experiences and perspectives drive us towards our aspiration to be the best human therapeutics company. We prioritize an inclusive, high-performing culture where every employee feels valued, supported, and empowered to contribute their full potential. Through platform such as our Employee Resource Groups (ERGs), we foster professional growth, create a sense of belonging, and tap into diverse viewpoints that empowers our employees to contribute to their full potential to serve every patient, every time.
Recognized consistently for our manufacturing innovation and as a top employer in Singapore, Amgen Singapore Manufacturing is committed to fulfilling our Corporate Purpose and making a meaningful contributions across five impact areas of People, Society, Governance, Environment and Economic.